These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

252 related items for PubMed ID: 19243013

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. MicroRNA-145 post-transcriptionally regulates the expression and function of P-glycoprotein in intestinal epithelial cells.
    Ikemura K, Yamamoto M, Miyazaki S, Mizutani H, Iwamoto T, Okuda M.
    Mol Pharmacol; 2013 Feb; 83(2):399-405. PubMed ID: 23166305
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. P-gp localization in mitochondria and its functional characterization in multiple drug-resistant cell lines.
    Solazzo M, Fantappiè O, Lasagna N, Sassoli C, Nosi D, Mazzanti R.
    Exp Cell Res; 2006 Dec 10; 312(20):4070-8. PubMed ID: 17027968
    [Abstract] [Full Text] [Related]

  • 28. Drug penetration model of vinblastine-treated Caco-2 cultures.
    Hellinger E, Bakk ML, Pócza P, Tihanyi K, Vastag M.
    Eur J Pharm Sci; 2010 Sep 11; 41(1):96-106. PubMed ID: 20595016
    [Abstract] [Full Text] [Related]

  • 29. Increased expression of MDR1 mRNAs and P-glycoprotein in placentas from HIV-1 infected women.
    Camus M, Deloménie C, Didier N, Faye A, Gil S, Dauge MC, Mabondzo A, Farinotti R.
    Placenta; 2006 Sep 11; 27(6-7):699-706. PubMed ID: 16165208
    [Abstract] [Full Text] [Related]

  • 30. Effect of hr-IL2 treatment on intestinal P-glycoprotein expression and activity in Caco-2 cells.
    Belliard AM, Tardivel S, Farinotti R, Lacour B, Leroy C.
    J Pharm Pharmacol; 2002 Aug 11; 54(8):1103-9. PubMed ID: 12195825
    [Abstract] [Full Text] [Related]

  • 31. Development of a highly sensitive method using liquid chromatography-multiple reaction monitoring to quantify membrane P-glycoprotein in biological matrices and relationship to transport function.
    Miliotis T, Ali L, Palm JE, Lundqvist AJ, Ahnoff M, Andersson TB, Hilgendorf C.
    Drug Metab Dispos; 2011 Dec 11; 39(12):2440-9. PubMed ID: 21949244
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Reversal of MDR1 gene-dependent multidrug resistance using low concentration of endonuclease-prepared small interference RNA.
    Li L, Xu J, Min T, Huang W.
    Eur J Pharmacol; 2006 Apr 24; 536(1-2):93-7. PubMed ID: 16564522
    [Abstract] [Full Text] [Related]

  • 38. Cytokine-induced killer cells showing multidrug resistance and remaining cytotoxic activity to tumor cells after transfected with mdr1 cDNA.
    Li HF, Yang YH, Shi YJ, Wang YQ, Zhu P.
    Chin Med J (Engl); 2004 Sep 24; 117(9):1348-52. PubMed ID: 15377427
    [Abstract] [Full Text] [Related]

  • 39. Suppression of P-glycoprotein gene expression in Hs578T/Dox by the overexpression of caveolin-1.
    Zhu H, Cai C, Chen J.
    FEBS Lett; 2004 Oct 22; 576(3):369-74. PubMed ID: 15498565
    [Abstract] [Full Text] [Related]

  • 40. Cyclooxygenase-2 inhibitors prevent trinitrobenzene sulfonic acid-induced P-glycoprotein up-regulation in vitro and in vivo.
    Zrieki A, Farinotti R, Buyse M.
    Eur J Pharmacol; 2010 Jun 25; 636(1-3):189-97. PubMed ID: 20361960
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.